Global anatomic pathology market is anticipated to grow at a CAGR of 8.5% during the forecast period (2024–2031). The market growth is attributed to the rising incidence, and prevalence of chronic diseases, such as liver and kidney disease, cancer, and infectious disease. Cancer cases are escalating rapidly across the globe, with the maximum patients suffering from lung, prostate, colorectal, and breast cancer.
Get Free Sample link @ https://www.omrglobal.com/request-sample/anatomic-pathology-market-size
Anatomic pathology products and services play an important role in oncology drug trials. They are employed to gather quantitative data, detect pharmacodynamics markers, and identify morphological structures. However, the availability of refurbished anatomic pathology instruments is one of the major challenges for market growth.
North America is estimated to hold a substantial share of the global anatomic pathology market. This is owing to the rising investment by government and academic research centers in diagnostic research and the incidence of lung cancer and other chronic disease. Additionally, factors such as the growing elderly population and increasing focus on biomarker research facilitate market expansion in this region. This market is further boosted by the presence of major players such as Abbott Laboratories in the region. Furthermore, the adoption of the Affordable Care Act and Healthcare reforms are expected to support the growth of the market during the forecast period.
Full report of Anatomic Pathology Market available @ https://www.omrglobal.com/industry-reports/anatomic-pathology-market-size
Recent Developments
- In July 2023, PathAI a provider of AI-powered pathology tools, announced the availability of AIM-HER2 breast cancer for research use by clinical laboratories, researchers, and drug developers. AIM-HER2 Breast Cancer delivers automated digital HER2 scoring and is the market’s first algorithm to use additive Multiple Instance Learning (aMIL) heatmaps to visualize the slide features driving the algorithm’s predicted score.
- In September 2022, Epredia’s parent company, PHC Holdings Corporation acquired anatomical pathology suppliers Micron Microtech France and Laurypath in a strategic expansion of Epredia’s presence in Europe.
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape: Danaher Corp., Agilent Technologies Inc., Abcam Plc, Abbott Laboratories, and F. Hoffman La Roche among others.
Global Anatomic Pathology Market Report Segment
By Products and services
- Consumables
- Services
- Instruments
By End-user
- Hospitals
- Clinical Laboratory
- Others (Research Institutes)
By Application
- Disease Diagnosis
- Drug Discovery
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/anatomic-pathology-market-size
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
